FUNDS
Our funds are designed to offer investors access to unique opportunities in Portugal’s dynamic mid-cap market.
Fundo Alqueva
Vintage year: 2024
Capital raised: Eur 40M
Number of Investments: 3
Investment focus: Secondaries and special situations
Industries: Infrastructure and critical logistics
Number of Exits: 0
Current Portfolio: Coremar, Coinsa and Atica
Fundo Audere
Vintage year: 2024
Capital raised: Eur 40M
Number of Investments: 3
Investment focus: Secondaries and special situations
Industries: Infrastructure and critical logistics.
Number of Exits: 0
Current Portfolio: Coremar, Coinsa and Atica
Fundo Inter-Risco Consolidar
Vintage year: 2023
Capital raised: Eur 65M
Number of Investments: 4
Investment focus: Growth/expansion
Industries: Education, agribusiness, health and infrastructure.
Number of Exits: 0
Current Portfolio: Veracruz, Atis Group, Esçolas João Paulo II and MB Education
Fundo Inter-Risco II CI
Vintage year: 2013
Capital raised: Eur 30M
Number of Investments: 6
Investment focus: Buy-outs, expansion and build-ups
Industries: Engineering services, scaffolding manufacturing and distribution, and hospitality
Number of Exits: 3
Exits: Express Glass, Mecwide and Catari
Current Portfolio: Stay Hotels, ENC Energy and NewCoffee.
Fundo Inter-Risco II
Vintage year: 2010
Capital raised: Eur 81.5M
Number of Investments: 8
Investment focus: Buy-outs, growth and build-ups
Industries: Veterinary services, dental clinics, cold logistics, engineering services, scaffolding manufacturing and distribution, and hospitality
Number of Exits: 6
Exits: 32 Senses, Onevet Group, Mecwide, Express Glass, Cold Land and Catari
Current Portfolio: Stay Hotels and ENC Energy.
CLOSED FUNDS
Fundo Caravela
Vintage year: 2003
End date: 2023
Capital raised: Eur 30M
Number of Investments: 6
Investment focus: build-up and buy-outs
Industries: Facility management services, autoinspection services, waste management, BPO services, manufacturing and distribution of coffee
Number of Exits: 6
Exits: Moneris, MasterTest, Douro Azul, Chipidea, Serlima and Sotkon.
